A health products company called Health Research Laboratories and its owner Kramer Duhon have agreed to settle charges by the Federal Trade Commission and the State of Maine that they deceived consumers with promises that their products could treat everything from arthritis to memory loss. The proposed federal court order announced today bars the defendants from engaging in a wide range of business practices that the agencies allege have caused financial injury to consumers.
According to the agencies’ complaint, the company and its owner marketed two of their products, BioTherapex, a dietary supplement that purportedly targets the liver to address a host of ailments, and NeuroPlus, a brain supplement, using a variety of false and unsupported claims.
The FTC's press release, with relevant links, is here.
